Pivotal Phase III Studies Presented During Digestive Disease Week (DDW) Show MMX Mesalamine (Mesavance(TM)) Induced (Medical News Today)
Combined results of two pivotalphase III clinical studies (301 and 302) of a novel formulation ofMulti-Matrix System(TM) (MMX) mesalamine, a medication currently underreview by the FDA, Canadian, and EU regulatory agencies, were presentedtoday during DDW at the Los Angeles Convention Center. [click link for full article]

MedSpa Solutions Awarded Contract by Irvine Plastic Surgeon (SYS-CON Media)
MedSpa Solutions Inc., a wholly owned subsidiaryof Winsted Holdings Inc. (OTCBB: WNSH), today announced that it was awardeda comprehensive consultancy contract by a physician in Irvine, California.This Contract covers Business Development, Core Site Design, VendorRelationships, Licensing & Compliance Assistance and Custom MarketingDevelopment.

Corautus Genetics warned of delisting (Atlanta Business Chronicle)
Corautus Genetics Inc. faces delisting from NASDAQ if it cannot get its trading price back above $1 a share for a minimum of 10 business days.